Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was EGP 450.43 million compared to EGP 368.44 million a year ago. Net income was EGP 49.16 million compared to EGP 52.41 million a year ago. Basic earnings per share from continuing operations was EGP 0.033 compared to EGP 0.0347 a year ago. Diluted earnings per share from continuing operations was EGP 0.0328 compared to EGP 0.0345 a year ago.
For the six months, sales was EGP 842.43 million compared to EGP 711.5 million a year ago. Net income was EGP 115.67 million compared to EGP 124.2 million a year ago. Basic earnings per share from continuing operations was EGP 0.0776 compared to EGP 0.0824 a year ago. Diluted earnings per share from continuing operations was EGP 0.077 compared to EGP 0.0818 a year ago.